Artal Group S.A. Portfolio Holdings

Artal Group S.A.

  • $188 Million
  • Q3 2025

Artal Group S.A. has filed its 13F form on November 12, 2025 for Q3 2025 where it was disclosed a total value porftolio of $188 Million distributed in 2 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Lexicon Pharmaceuticals, Inc. with a value of $188M and Cava Group Inc with a value of $0.

Examining the 13F form we can see an increase of $58.6M in the current position value, from $129M to 188M.

Artal Group S.A. is based out at Luxembourg, N4

Below you can find more details about Artal Group S.A. portfolio as well as his latest detailed transactions.

Portfolio value $188 Million
Healthcare: $188 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$268M
$188 Million 100.0% of portfolio
136,180,481
Q3 2024 Reduced 22.23%
Cava Group Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 45.69%

Summary

  • Portfolio
  • No. of Stocks 2
  • Current Value $188 Million
  • Prior Value $129 Million
  • Filing
  • Period Q3 2025
  • Filing Date November 12, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Artal Group S.A. Portfolio

Follow Artal Group S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

News

Stay updated on Artal Group S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email